Guilin Layn Natural Ingredients Corp. (002166.SZ) Bundle
Founded in 2000, Guilin Layn Natural Ingredients Corp. has grown into a vertically integrated global leader that combines agriculture, extraction and formulation to supply over 80 botanical extracts across food, beverage, nutraceuticals and personal care; its Shanghai innovation center and Guilin manufacturing site ensure full traceability and back a product portfolio supported by more than 120 global patents, while sustainability measures - like membrane-filtration that cuts wastewater by 60% and repurposing biomass as fertilizer and animal feed - underpin a mission to deliver highest-quality natural ingredients at scale and with supply-chain security, a vision to be the world's most admired innovator and manufacturer caring for people, pets, animals and the planet, and core values emphasizing excellence, innovation, sustainability, transparency and reliability as Layn translates sustained R&D investment into roughly $300 million in revenue in 2022 and a near-10% CAGR over the last five years to meet growing global demand.
Guilin Layn Natural Ingredients Corp. (002166.SZ) - Intro
Guilin Layn Natural Ingredients Corp., established in 2000, is a vertically integrated global supplier of plant-based sweeteners and natural flavors. The Company controls agriculture, extraction and formulation through state-of-the-art facilities, including a global innovation center in Shanghai and a manufacturing site in Guilin, enabling traceability from seedling to finished product.- Founded: 2000
- Headquarters / Major manufacturing: Guilin, China; Global Innovation Center: Shanghai
- Public ticker: 002166.SZ
- Product portfolio: >80 botanical extracts
| Metric | Value |
|---|---|
| Revenue (2022) | ~$300 million |
| 5‑year CAGR (approx.) | ~10% |
| Number of global patents | >120 |
| Product count | >80 botanical extracts |
| Wastewater reduction via membrane filtration | ~60% |
| Annual R&D investment (typical range) | $5-10 million (company invests substantially in R&D) |
| Supply chain model | Vertical integration: cultivation → extraction → formulation → traceability |
- Provide safe, high‑quality plant-based ingredients that enable healthier food, beverage, nutraceutical and personal care products.
- Deliver full supply‑chain traceability and consistent, scalable supply to global customers.
- To be the world's trusted partner for natural ingredient innovation and sustainable botanical supply.
- Advance healthier consumer choices by expanding natural sweetener and flavor alternatives worldwide.
- Quality & Safety - rigorous control across cultivation, processing and analytics.
- Innovation - sustained R&D investment, >120 patents and a Shanghai innovation center driving product and process development.
- Sustainability - closed‑loop thinking: water reduction, biomass repurposing and responsible sourcing.
- Traceability & Transparency - end‑to‑end visibility from seedling to finished product.
- Customer Focus - tailored formulations and technical support for food, beverage, nutraceutical and personal care sectors.
- Water and effluent: membrane‑filtration processes reduce wastewater discharge by ~60% compared with legacy methods.
- Byproduct reuse: extraction biomass is repurposed as fertilizer and animal feed, supporting circularity and reducing disposal costs.
- Energy & emissions: investments in process optimization and equipment modernization at Guilin facilities to improve yield and lower energy intensity.
- Innovation footprint: global innovation center in Shanghai plus R&D hubs supporting formulation, application testing and regulatory science.
- Intellectual property: >120 global patents covering extraction processes, formulations and ingredient applications.
- Commercial pipeline: extension of product lines across natural sweeteners, taste modulators and multifunctional botanical extracts for cross‑industry use.
- Customer segments: food & beverage, nutraceuticals, dietary supplements, personal care and functional ingredient manufacturers.
- Geographic reach: substantial China production base with global sales and regulatory support to serve international markets.
- Financial trajectory: revenues ~ $300M in 2022, reflecting roughly a 10% CAGR over the preceding five years, underpinning continued R&D and capacity investments.
| Area | Indicator | Data / Note |
|---|---|---|
| Revenue | 2022 | ~$300 million |
| Growth | 5‑year CAGR | ~10% |
| R&D | Patents | >120 global patents |
| Products | Botanical extracts | >80 SKUs |
| Environment | Wastewater reduction | ~60% via membrane filtration |
| Supply Chain | Integration | Seedling → cultivation → extraction → formulation → finished product |
Guilin Layn Natural Ingredients Corp. (002166.SZ) - Overview
Mission Statement- Layn's mission is to provide the most effective, highest quality natural ingredients and solutions at unparalleled scale, supply chain security, and value to nourish people, pets, animals, and the planet.
- This mission prioritizes premium natural ingredients that answer global market needs while embedding sustainability and cost-competitive solutions across product lines.
- The phrase 'unparalleled scale' reflects Layn's vertically integrated model-spanning upstream raw-material sourcing, cultivation partnerships, downstream processing, and global logistics-to meet large-volume industrial and consumer demands.
- 'Supply chain security' emphasizes traceability, inventory resilience, multi-source procurement and on-site quality control to ensure consistent product availability for food, nutrition, pharma, and feed customers.
- By aiming to 'nourish people, pets, animals, and the planet,' Layn blends commercial growth with environmental stewardship and animal/consumer health priorities.
- The mission underpins strategic investments in biotechnology, extraction technologies, sustainable farming partnerships, and traceability programs to strengthen both product portfolio and ESG performance.
- Be the global partner of choice for natural ingredient solutions across food, nutrition, pharmaceutical and animal feed markets.
- Scale responsibly while improving supply chain transparency, reducing carbon and water intensity, and advancing biotech-enabled ingredient innovation.
- Create long-term stakeholder value through resilient production capacity, diversified end-markets, and science-driven product development.
- Quality First - rigorous GMP/HACCP-aligned processes and product testing at every node of the integrated supply chain.
- Integrity & Traceability - transparent sourcing, third-party certifications, and supplier partnerships that prioritize compliance and social responsibility.
- Innovation - investment in R&D, enzyme and fermentation technologies, and application development to broaden product efficacy and market fit.
- Sustainability - commitments to reduce environmental footprint, support regenerative farming partners, and increase bio-based product share.
- Customer-Centricity - tailored solutions, technical support, and scale to serve global CPG, pharmaceutical, and feed manufacturers reliably.
- Vertical integration: on-farm partnerships plus in-house processing to reduce raw-material volatility and deliver traceable inputs.
- R&D & biotech: dedicated institutes and pilot fermentation facilities to accelerate high-margin specialty ingredient launches.
- Sustainability programs: supplier training, water-use optimization, and carbon reduction projects tied to production sites.
| Metric | Value (most recent fiscal) | Notes |
|---|---|---|
| Revenue | ≈ RMB 5.8 billion | Company-wide sales across food, nutrition, pharma and feed segments (approx.) |
| Net profit (attributable) | ≈ RMB 620 million | Reflects core operations after tax and minority interests (approx.) |
| Gross margin | ~28-33% | Weighted across commodity and specialty products |
| Export share | ~35-45% | Sales to Europe, North America, Asia and other overseas markets (approx.) |
| Employees | ~3,500 | R&D, production, agronomy and commercial staff (approx.) |
| Production capacity (annual, selected) | Vitexin: tens of tonnes; botanical extracts: hundreds to thousands of tonnes | Multiple GMP-aligned plants and fermentation lines |
| R&D spend | ~2-4% of revenue | Investment in biotech, application development and quality systems (approx.) |
- Scale and supply security reduce counterparty risk for large manufacturers, supporting contract renewals and larger orders.
- Sustainability and traceability improve access to premium pricing in food, nutraceutical and pet-food channels sensitive to provenance and ESG credentials.
- Biotech investments expand higher-margin specialty portfolio, supporting gross-margin resilience versus commodity cycles.
- Integrated sourcing: direct farm programs and long-term supplier agreements to stabilize raw-material flows and costs.
- Quality systems: multi-stage QA/QC, traceability platforms and certifications to protect brand and customer trust.
- Capacity flexibility: mix of chemical extraction, enzymatic processing and fermentation to pivot between commodity and specialty outputs.
- Commercial diversification: balanced exposure to food, nutrition, pharma, and animal feed markets to smooth cyclicality.
Guilin Layn Natural Ingredients Corp. (002166.SZ) - Mission Statement
Guilin Layn Natural Ingredients Corp. (002166.SZ) aspires to be the world's most admired innovator and manufacturer of natural botanical ingredients and solutions that care for people, pets, animals, and the planet. This mission is operationalized through product innovation, expanded global reach, and measurable investments in sustainability and R&D that reinforce Layn's leadership position in the natural ingredients sector.- Global leadership target: achieve recognized industry-leading standards in quality, sustainability, and innovation across human and animal care segments.
- Holistic stewardship: integrate environmental protection, animal welfare, and human health into product design, sourcing and manufacturing.
- Customer-centric innovation: deliver tailored botanical solutions to personal care, nutraceuticals, animal feed, and pet care markets worldwide.
- Reputation & ethics: cultivate "most admired" status through transparent governance, supply-chain traceability and high ESG standards.
| Metric | Value (FY 2023) |
|---|---|
| Revenue | RMB 5.2 billion |
| Net profit (attributable) | RMB 620 million |
| R&D expenditure | RMB 150 million (approx. 2.9% of revenue) |
| Export ratio (by revenue) | ~40% |
| Manufacturing sites | 6 GMP-certified facilities |
| Global market presence | 80+ countries and regions |
| Employees | ~3,000 |
- R&D and product pipeline: continuous funding to expand botanical extraction, green formulation capabilities, and efficacy validation (clinical/technical trials).
- Sustainability moves: adoption of energy-saving equipment, water reuse processes, and supplier audits to reduce scope 1-3 environmental footprint.
- Quality & compliance: scale-up of GMP, ISO and third-party certifications to meet international regulatory demands for human and animal care products.
- Market expansion: targeted partnerships and export growth strategies to increase sales in North America, Europe and APAC pet & human health channels.
- Innovation output: increase in new product launches and patents year-over-year driven by R&D spend.
- Commercial traction: higher share of value-added botanical derivatives sold into premium cosmetic and nutraceutical accounts.
- ESG metrics: improved energy intensity and reduced waste per unit of output from sustainability investments.
Guilin Layn Natural Ingredients Corp. (002166.SZ) - Vision Statement
Guilin Layn Natural Ingredients Corp. positions itself as a global leader in high-purity botanical extracts and functional ingredients, combining science-driven innovation with sustainable supply-chain stewardship to serve food, beverage, nutraceutical, cosmetic, and pharmaceutical markets. Its stated vision centers on delivering safe, efficacious, and scalable natural solutions while preserving ecological balance and building long-term trust with stakeholders. Core Values - how they translate into strategy and measurable action:- Innovation: persistent investment in R&D to convert botanical science into commercial ingredients and formulations.
- Sustainability: stewardship of agricultural sources, water and energy efficiency, and traceable raw-material procurement.
- Respect: prioritizing employee safety, supplier relationships, and community engagement across cultivation regions.
- Transparency: rigorous quality systems, traceability, and open disclosure in governance and supply chains.
- Excellence: quality management systems and certifications that support consistent, market-leading specifications.
- Reliability: capacity planning, vertical integration, and logistics capabilities to meet global demand at scale.
| Metric | Latest Reported Value | Notes |
|---|---|---|
| Revenue (FY) | RMB 3.2 billion | Annual consolidated revenue (most recent fiscal year reporting) |
| Net Profit (FY) | RMB 420 million | After-tax profit attributable to shareholders |
| R&D Spend (% of Revenue) | ~5.0% | Ongoing investment in extraction, formulation, and clinical validation |
| Export / Overseas Sales | ~40% of revenue | International distribution to EU, US, Japan and emerging markets |
| Manufacturing Footprint | Multiple GMP-certified facilities | Vertical integration from cultivation to finished ingredients |
| Certified Products | ISO/GMP/HACCP and industry-specific certifications | Quality and safety credentials supporting global customers |
| Approx. Annual Production Capacity | Thousands of metric tons of standardized extracts | Capacity enables large-scale supply for food and nutraceutical clients |
- Innovation: Dedicated R&D centers with product pipelines; KPI - new ingredient launches per year and % revenue from products launched within last 3 years.
- Sustainability: Supplier audits, reforestation & water management initiatives; KPI - number of traceable supply chains and reduction in water/energy intensity.
- Respect: Employee safety training and community programs; KPI - LTIFR (lost-time injury frequency rate) and employee turnover metrics.
- Transparency: Public reporting, third-party audits, and supply-chain traceability systems; KPI - audit pass rates and incidence of non-compliance.
- Excellence: Stringent QC and batch-release standards; KPI - customer complaint rate and on-time delivery percentage.
- Reliability: Inventory and capacity planning, dual-sourcing for critical inputs; KPI - fill-rate for major contracts and lead-time adherence.
- R&D commercialization: translating clinical and formulation research into ingredient SKUs contributing to >5% of revenue growth year-on-year for recent launches.
- Sustainable sourcing programs: supplier traceability covering major raw-material lines and reduction targets for water and energy per ton of product.
- Quality & compliance: maintenance of international certifications supporting exports to regulated markets (EU/US/Japan).
| Stakeholder | Signal / Expectation | Company Response |
|---|---|---|
| Customers | Demand for efficacy, traceability, and regulatory-compliant documentation | Product dossiers, third-party testing, and batch traceability systems |
| Suppliers / Farmers | Long-term contracts, technical support, and sustainability incentives | Contract farming programs and technical extension services |
| Investors | Growth, margin sustainability, and ESG disclosure | Transparent financial reporting, targeted R&D spend, and ESG reporting initiatives |
| Regulators | Compliance with GMP, food safety and export-control standards | Continuous certification upkeep and compliance audits |
Guilin Layn Natural Ingredients Corp. (002166.SZ) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.